Related Experiment Video
Updated: Jan 13, 2026

Vascularized Composite Upper Limb Allograft Harvesting for Proximal Arm Allotransplantation
Published on: June 13, 2025
The Risk Profile of Face Transplant Versus Other Types of Vascularized Composite Allotransplantation Surgery-A
Jillian Dean1, Tobias Niederegger2, Thomas Schaschinger2
1University of Pittsburgh School of Medicine, Pittsburgh, PA.
Background:
Vascularized composite allotransplantation (VCA) represents a transformative advance in reconstructive surgery, offering restoration of essential functions and psychological well-being for individuals with severe facial trauma or anomalies. There are different types of VCA. Facial vascularized composite allotransplantation (FVCA) is a complex procedure that carries the potential risk of severe complications in the event of rejection. There is a paucity of research that compares outcomes following FVCA to other types of VCA.
Methods:
Data were retrieved from the Organ Procurement and Transplantation Network (OPTN) database, which provides comprehensive information on all US organ donation and transplant activities. A search identified 96 eligible VCA cases, consisting of 16 FVCAs and 80 non-FVCA cases that were included in the final analysis.
Results:
In facial vascularized composite allotransplantation (FVCA) recipients, the median number of acute rejection episodes was significantly higher compared with non-FVCA patients [5.0 (IQR=0.0-10) versus 0.0 (IQR=0.0-2.0), P =0.0022]. Similarly, the median number of hospitalizations was greater in FVCA patients [3.0 (IQR=0.75-4.0) versus 0.0 (IQR=0.0-1.0), P <0.001]. While the overall complication rates did not differ significantly between groups (44% versus 25%, P =0.14), infectious complications were notably more frequent in FVCA recipients (44% versus 15%, P =0.015).
Conclusion:
Facial vascularized composite allotransplantation (FVCA) stands out from VCA procedures due to its heightened immunologic complexity and unique clinical challenges, including high antigenicity from the included skin, presensitized patients, and visible grafts. Facial vascularized composite allotransplantation (FVCA) demands stronger immunosuppression and intensive perioperative monitoring to manage complications. Continued efforts to optimize these strategies are crucial to reduce morbidity and improve outcomes, ensuring FVCA's transformative potential is realized safely and effectively.
More Related Videos
05:34A Reliable Porcine Fascio-Cutaneous Flap Model for Vascularized Composite Allografts Bioengineering Studies
Published on: March 31, 2022
09:36Modified Heterotopic Hindlimb Osteomyocutaneous Flap Model in the Rat for Translational Vascularized Composite Allotransplantation Research
Published on: April 26, 2019
Related Concept Videos
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant I: Introduction